Business Context and Reporting Period
Company: Globus Medical, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: July 25, 2016
Event: Entry into a Material Definitive Agreement to acquire international assets and subsidiaries from Alphatec Holdings, Inc.
Key Financial Metrics
This filing reports on a specific transaction rather than periodic financial performance. Consequently, standard metrics such as revenue, profit, cash flow, margins, and existing debt levels are not provided in this document.
- Transaction Consideration: Approximately $80 million in cash (subject to customary working capital adjustments).
- Financing Arrangement: Globus Medical will provide Alphatec with a senior secured term loan facility not to exceed $30 million.
- Loan Terms: Five-year scheduled maturity; includes customary financial and operational covenants; secured by all assets of Alphatec.
Material Changes
The primary material change is the proposed expansion of Globus Medical's international footprint through the acquisition of Alphatec's international business operations.
- Assets Acquired: Substantially all assets and certain liabilities of Alphatec subsidiaries in the United Kingdom, Italy, the Netherlands, France, Germany, and Hong Kong.
- Equity Acquired: All outstanding equity interests of Alphatec subsidiaries in Japan, Brazil, China, Singapore, and Australia.
- Operational Change: Entry into a five-year Supply Agreement where Alphatec will supply products to Globus Ireland and the newly acquired subsidiaries.
Outlook, Risks, and Contingencies
Expected Closing: The acquisition is expected to close by October 2016.
Risks and Contingencies:
- Closing Conditions: Consummation is subject to customary closing conditions. There is no assurance these conditions will be satisfied.
- Adjustments: The final purchase price is subject to adjustment based on working capital items.
- Regulatory Status: Information regarding the press release is deemed "furnished" and not "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Verify the satisfaction of all customary closing conditions prior to the expected October 2016 closing date.
- Confirm the final purchase price after working capital adjustments are calculated.
- Review the full text of the Purchase and Sale Agreement (Exhibit 2.1) for specific representations, warranties, and indemnification provisions.
- Assess the impact of the new $30 million secured term loan on the company's future debt covenants and liquidity.
- Monitor the execution of the five-year Supply Agreement with Alphatec.